Dual modulation of MCL-1 and mTOR determines the response to sunitinib
Mohamed Elgendy(German Cancer Research Center), Saverio Minucci(University of Milan)
Cited by 57
Related Papers
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
|Nature reviews. Cancer|2006|2.2k
Impairment of p53 acetylation, stability and function by an oncogenic transcription factor
|The EMBO Journal|2004|118
Beclin 1 restrains tumorigenesis through Mcl-1 destabilization in an autophagy-independent reciprocal manner
|Nature Communications|2014|84
Endogenous PP2A inhibitor CIP2A degradation by chaperone-mediated autophagy contributes to the antitumor effect of mitochondrial complex I inhibition
|Cell Reports|2023|15
MCL1 modulates mTORC1 signaling to promote bioenergetics and tumorigenesis
|Nature Communications|2025|3